# Novartis AG (NVS)

Novartis AG hits new 52-week and all-time highs, driven by acquisition news and strong social media buzz around drug advancements and pricing discussions.

### About Novartis AG
Novartis AG is a global pharmaceutical company.  
Novartis AG uses the ticker $NVS for trading. Listed in the [Stocks](/list/stocks) category within the [Healthcare](/list/stocks/healthcare) sectors.

### Insights
- Novartis AG (NVS) social dominance is up 74.5% from the previous week.
- Novartis AG (NVS) Galaxy Score™ is up 25% from the previous week.
- Novartis AG (NVS) sentiment is up 21.33% from the previous week.
- Novartis AG (NVS) creators is up 79.46% from the previous month.
- Novartis AG (NVS) mentions is up 71.28% from the previous month.
- Novartis AG Price hit a 52-Week high of $163.40 for the hour
- Novartis AG Price hit an all time of $163.40 for the hour

### Price: $163.10
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:novartis/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/novartis/time-series/close.tsv)  
The stock price has reached a 52-week and all-time high, driven by positive news regarding potential drug pricing deals and the acquisition of Avidity Biosciences, supported by strong social media engagement.  

24-Hour: 1.38%
7-Day: 4.4%
30-Day: 13%

1-Year High: $163.10 on 2026-02-13  
1-Year Low: $102 on 2025-04-08  
  
  
### AltRank: [---]
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:novartis/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/novartis/time-series/alt_rank.tsv)  
Novartis AG (NVS) is currently AltRank #329 based on combined combined social and market metrics
Daily Average: [---]  
[--] Week: [---] +404  
[--] Month: [---] [----]  
[--] Months: [---] [----]  
[--] Year: [---] [----]  
1-Year High: [-----] on 2025-06-30  
1-Year Low: [--] on 2025-07-05  
  
  
### Galaxy Score: [-----]
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:novartis/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/novartis/time-series/galaxy_score.tsv)  
Current Value: [-----]  
Daily Average: [--]  
[--] Week: [--] +11  
[--] Month: [--] [---]  
[--] Months: [--] +4  
[--] Year: [--] [---]  
1-Year High: [--] on 2025-05-20  
1-Year Low: [--] on 2025-07-28  
  
  
### Engagements: [-------] (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:novartis/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/novartis/time-series/interactions.tsv)  
Current Value: [-------]  
Daily Average: [-------]  
[--] Week: [---------] -38%  
[--] Month: [----------] +254%  
[--] Months: [----------] +198%  
[--] Year: [-----------] +183%  
1-Year High: [---------] on 2025-11-28  
1-Year Low: [------] on 2026-01-11  

Engagements by network (24h):
X: [------]
TikTok: [-----]
News: [--]
YouTube: [-------]
Reddit: [---]
Instagram: [---]

  
  
### Mentions: [---] (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:novartis/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/novartis/time-series/posts_active.tsv)  
Current Value: [---]  
Daily Average: [---]  
[--] Week: [-----] +14%  
[--] Month: [-----] +71%  
[--] Months: [------] +32%  
[--] Year: [------] +197%  
1-Year High: [-----] on 2026-02-06  
1-Year Low: [---] on 2025-07-01  

Mentions by network (24h):
X: [---]
TikTok: [--]
News: [--]
YouTube: [--]
Reddit: [--]
Instagram: [--]

  
  
### Creators: [---] (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:novartis/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/novartis/time-series/contributors_active.tsv)  
[---] unique social accounts have posts mentioning Novartis AG (NVS) in the last [--] hours which is down 14% from [---] in the previous [--] hours
Daily Average: [---]  
[--] Week: [-----] +15%  
[--] Month: [-----] +79%  
[--] Months: [-----] +31%  
[--] Year: [------] +166%  
1-Year High: [---] on 2026-02-06  
1-Year Low: [---] on 2025-07-01  

The most influential creators that mention Novartis AG in the last [--] hours

| Creator                                          | Rank | Followers  | Posts | Engagements |
| -------                                          | ---- | ---------  | ----- | ----------- |
| [@upediashorts](/creator/youtube/upediashorts)   | [--]    | [----------] | [--]    | [-------]     |
| [@StockMKTNewz](/creator/twitter/StockMKTNewz)   | [--]    | [-------]    | [--]     | [------]      |
| [@theplayerstv](/creator/tiktok/theplayerstv)    | [--]    |            | [--]    | [-----]       |
| [@theboobiedocs](/creator/tiktok/theboobiedocs)  | [--]    | [------]     | [--]     | [---]         |
| [@novartis011](/creator/tiktok/novartis011)      | [--]    | [--]         | [--]     | [---]         |
| [@grok](/creator/twitter/grok)                   | [--]    | [---------]  | [--]    | [---]         |
| [@WSJbusiness](/creator/twitter/WSJbusiness)     | [--]    | [---------]  | [--]     | [---]         |
| [@FareedZakaria](/creator/twitter/FareedZakaria) | [--]    | [---------]  | [--]     | [---]         |
| [@MasendeMbuzi](/creator/twitter/MasendeMbuzi)   | [--]    | [---]        | [--]     | [---]         |
| [@raw_sunday](/creator/twitter/raw_sunday)       | [--]   | [-----]      | [--]     | [---]         |

[View More](/list/creators/novartis/100)
  
  
### Sentiment: 92%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:novartis/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/novartis/time-series/sentiment.tsv)  
Current Value: 92%  
Daily Average: 86%  
[--] Week: 91% +16%  
[--] Month: 88% +3%  
[--] Months: 88% +2%  
[--] Year: 88% -8%  
1-Year High: 98% on 2026-01-24  
1-Year Low: 22% on 2025-08-26  

Most Supportive Themes:
- WHO Partnership for Leprosy Elimination: (30%) Novartis AG's long-standing partnership with the WHO to provide free multidrug therapy for leprosy and support single-dose rifampicin.
- Acquisition of Avidity Biosciences: (30%) Novartis AG is acquiring Avidity Biosciences for $12 billion, aiming to strengthen its neuroscience pipeline.
- Pipeline Advancements: (20%) Novartis AG is presenting new treatments, including for Sjogren's disease, and has advanced its RNA therapeutics.
- Positive Financial Performance: (20%) Novartis AG reported solid sales and core operating income growth in Q3 2025, driven by new cancer medicines.
  
Most Critical Themes:
- Drug Pricing and Access Concerns: (60%) There are ongoing discussions and concerns regarding the pricing of Novartis's drug Pluvicto and patient access programs.
- Past Legal Issues: (40%) Novartis AG has faced past settlements related to kickbacks and co-pay fraud.
  
  
  
### Social Dominance: 0.035%
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:novartis/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/novartis/time-series/social_dominance.tsv)  
Current Value: 0.035%  
Daily Average: 0.062%  
[--] Week: 0.113% +0.048%  
[--] Month: 0.058% +0.014%  
[--] Months: 0.058% +0.0094%  
[--] Year: 0.058% -0.018%  
1-Year High: 0.143% on 2026-02-06  
1-Year Low: 0.026% on 2025-07-01  
  
  
### Market Dominance: 0.353%
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:novartis/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/novartis/time-series/market_dominance.tsv)  
Current Value: 0.353%  
Daily Average: 0%  
1-Year High: 8.30% on 2025-03-31  
1-Year Low: 0.278% on 2025-10-29  
  
  
### Market Cap: $311,791,984,349
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:novartis/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/novartis/time-series/market_cap.tsv)  
Current Value: $311,791,984,349  
Daily Average: $240,724,492,432  
[--] Week: $311,791,984,349 +4.50%  
[--] Month: $311,791,984,349 +14%  
[--] Months: $311,791,984,349 +30%  
[--] Year: $311,791,984,349 +50%  
1-Year High: $311,791,984,349 on 2026-02-14  
1-Year Low: $201,380,099,726 on 2025-04-08  

### Top Novartis AG Social Posts
Top posts by engagements in the last [--] hours

*Showing a maximum of [--] top social posts without a LunarCrush subscription.*

".    @AdonisGeorgiadi.   NOVARTIS     (   @atsipras)"  
[X Link](https://x.com/Nicos1270647/status/2022529453360812289) [@Nicos1270647](/creator/x/Nicos1270647) 2026-02-14T04:32Z [---] followers, [----] engagements


"@Trevornoah @Novartis @Ibra_official @IAMQUEENLATIFAH @latinomuseum @the1975 @LatinoVoices @Latincouver @Latinamd @CYDLatinxCaucus @MadridXtra @BarcelonaAtleti @NBAspain @selenagomez #_ # #OlimpiadiInvernali2026 #provadolder #RISERCONCERTDAY1 #SB19VISA We are now above [----] Please help the petition to parliament reach [-----] signatures. Have you signed https://t.co/U48eZ62K8X https://t.co/DDn03ICtav We are now above [----] Please help the petition to parliament reach [-----] signatures. Have you signed https://t.co/U48eZ62K8X https://t.co/DDn03ICtav"  
[X Link](https://x.com/kfshoa/status/2022522046727831955) [@kfshoa](/creator/x/kfshoa) 2026-02-14T04:03Z [--] followers, [---] engagements


"@rkun_mhtdn I remember Nielsen being there because of NicoB let's play comments and I think they mention Novartis But yeah I will rewatch it later 3rd is a game that just keep going up on my tier list"  
[X Link](https://x.com/uiulex/status/2022500516048310623) [@uiulex](/creator/x/uiulex) 2026-02-14T02:37Z [---] followers, [---] engagements


"atrasentan Novartis Says Vanrafia Drug Slows Kidney Function Decline $NVS https://www.wsj.com/health/pharma/novartis-says-vanrafia-drug-slows-kidney-function-decline-3fa69239 https://www.wsj.com/health/pharma/novartis-says-vanrafia-drug-slows-kidney-function-decline-3fa69239"  
[X Link](https://x.com/BarbarianCap/status/2022498786287751493) [@BarbarianCap](/creator/x/BarbarianCap) 2026-02-14T02:31Z 47.4K followers, [---] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing